News Focus
News Focus
Replies to #72481 on Biotech Values
icon url

mouton29

01/30/09 9:19 PM

#72484 RE: drbio45 #72481

Re: seeking Alpha -- <<What he basically said was that he bought a stock and it went down. He will now learn from his mistake and wait before he gets fooled again.>>

Not so. He fell victim to one of the classic blunders. To quote Vizzini in The Princess Bride:

"You fell victim to one of the classic blunders! The most famous is never get involved in a land war in Asia, but only slightly less well-known is this: never go in against a Sicilian when death is on the line!"

Now, in the director's cut of the movie, Vizzini added:

"it usually isn't wise to buy a stock that is trading below its 200-day moving average unless you have compelling evidence to do otherwise."
icon url

DewDiligence

02/04/09 2:01 AM

#72684 RE: drbio45 #72481

SeekingAlpha stupidity just reached a new height:

http://seekingalpha.com/article/118170-will-pfizer-wyeth-product-overlap-present-antitrust-problems

Will Pfizer-Wyeth Product Overlap Present Antitrust Problems?

February 03, 2009

The first and most glaring product overlap associated with the Pfizer (PFE) - Wyeth (WYE) deal involves WYE's "Effexor" and PFE's "Zoloft" antidepressant drugs. These are two of the top antidepressants on the market and among the most highly marketed and internationally recognized products in this segment.

As the chart below from 2006 illustrates, Effexor and Zoloft each have close to 20% of this lucrative market, so the combined entity would have close to 40% of the overall market. Granted, this data is almost four years old, but it is believed to closely reflect the current market conditions for this particular product niche.

Not exactly! Zoloft went generic in June 2006:

http://www.fda.gov/bbs/topics/NEWS/2006/NEW01404.html

LMAO